EPHA5 and ovarian benign neoplasm: Downregulation of EPHA5 seems to contribute to carcinogenesis, since from normal fallopian tissues and benign ovarian neoplasms to borderline tumors and serous carcinomas, a progressive loss of EPHA5 expression was noted [79].